Bruker Corporation Majority Investment in RECIPE Chemicals + Instruments GmbH

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

Bruker Corporation Acquires Prolab Instruments GmbH

January 19, 2022

Medical Devices

Bruker Corporation (Nasdaq: BRKR) has acquired Prolab Instruments GmbH, a Swiss developer of low-flow, high-precision UHPLC pumps, autosamplers and nano-/cap-LC systems, to strengthen its proteomics and metabolomics workflows. Financial terms were not disclosed; Bruker said the acquisition will accelerate product innovation and improve single-cell and high-sensitivity proteomics capabilities.

Bruker Corporation Acquires PhenomeX Inc.

August 17, 2023

Biotechnology

Bruker Corporation agreed to acquire PhenomeX Inc. in an all-cash transaction valued at roughly $108 million (purchase price $1.00 per share). PhenomeX — formed from the combination of Berkeley Lights and IsoPlexis and provider of single-cell biology instruments, software and reagents — will be folded into a Bruker subsidiary, marking Bruker’s entry into single-cell biology research tools and complementing its spatial biology offerings.

908 Devices Acquires TRACE Analytics GmbH

August 9, 2022

Medical Devices

908 Devices (Nasdaq: MASS) has completed the acquisition of TRACE Analytics GmbH, a Braunschweig, Germany-based provider of on-line aseptic sampling systems and biosensors for bioreactor monitoring. The purchase consideration includes $15.3 million in cash up front plus up to $2.0 million of contingent consideration, and 908 Devices says the acquisition will enable its mass spec devices to perform on-line bioprocess monitoring and advance its bioanalytics platform.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.

Calibre Scientific Acquires Chemos GmbH & Co. KG

May 16, 2023

Manufacturing

Calibre Scientific has acquired Chemos GmbH & Co. KG, a Germany-based supplier of ready-to-use laboratory chemicals, reagents, standards and production raw materials. The acquisition adds Chemos' sourcing, formulation and toll-manufacturing capabilities to Calibre's global life-science portfolio to expand product offerings and support customers across analytical, chemical, food and pharmaceutical end markets.